Company Filing History:
Years Active: 2010-2011
Title: Innovations by Nick Occleston: Pioneering Advances in TGF-β3 Technology
Introduction
Nick Occleston is a prominent inventor based in Manchester, GB, recognized for his contributions to the field of biotechnology. With a total of four patents to his name, his work focuses primarily on transforming the applications of TGF-β3 proteins in medical treatments.
Latest Patents
Occleston’s latest innovations include patents centered around TGF-β3 mutants, which offer innovative approaches to enhance the functionality of TGF-β3 proteins. One of his key inventions provides TGF-β3s, or their fragments and derivatives, featuring alpha-helix-stabilizing substitutions in crucial regions. This enhances their efficacy in therapeutic applications. Another significant patent involves the use of monomeric TGF-β3 proteins, which are designed to promote wound healing and reduce scarring. These medicaments serve to improve epithelial regeneration and hold promise for treating various fibrotic disorders.
Career Highlights
Nick Occleston has made notable strides in his career, particularly during his tenure at Renovo Limited, where he has developed groundbreaking treatments that leverage TGF-β3 technology. His work is not only advancing scientific knowledge but also translating into real-world medical applications that can significantly impact patient care.
Collaborations
Throughout his career, Occleston has collaborated with esteemed colleagues such as Sharon O'Kane and Hugh Gerard Laverty. These partnerships have fostered an environment of innovation and creative problem-solving, critical for advancing their shared goals in biotechnology.
Conclusion
With his impressive portfolio of patents and ongoing research initiatives, Nick Occleston stands out as a significant contributor to advancing TGF-β3 technology. His work not only showcases his inventive spirit but also emphasizes the potential for innovations in medicine that can lead to improved patient outcomes.